Profile
DHR-PA DHR-PB TMO DHR IDXX A
Company Name Danaher Corporation Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap - $916.76B $219.61B $165.09B $53.50B $39.11B
Employees 78.00K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO - Rainer M. Blair Marc N. Casper Rainer Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
DHR-PA DHR-PB TMO DHR IDXX A
Quant Rating Score 3 5 3 3 3 3
Quant Rating Neutral Strong Buy Neutral Neutral Neutral Neutral
Trading
DHR-PA DHR-PB TMO DHR IDXX A
Last Close $1841.01 $1261.26 $567.16 $220.44 $669 $144.52
High 52 $1841.01 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $1841.01 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High 0 % 0 % -6.52 % -12.03 % -7.46 % -5.29 %
Price vs. 52 Week Low 0 % 0 % 45.35 % 26.23 % 85.3 % 45.55 %
Total Return
DHR-PA DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % 5.24 % 5.44 % 5.29 % 1.83 %
3 Month Return 0 % 0 % 16.29 % 5.47 % 4.88 % 22.32 %
6 Month Return 0 % 0 % 37.64 % 12.41 % 29.13 % 27.03 %
9 Month Return 0 % 0 % 8.42 % 7.78 % 48.98 % 6.89 %
YTD Return 0 % 0 % 9.02 % -3.97 % 61.81 % 7.58 %
1 Year Return 0 % 0 % 11.4 % -4.51 % 60.69 % 14.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DHR-PA DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) 0.54 % 0.56 % 0.3 % 0.56 % - 0.72 %
Dividend Paid and Capex Coverage Ration (TTM) 2.94 % 2.94 % 3.54 % 2.94 % 8.09 % 2.26 %
Dividend Per Share (TTM) 1.28 % 1.28 % 1.72 % 1.28 % - 0.99 %
Payout Ratio (TTM) 24.18 % 24.18 % 9.48 % 24.18 % - 21.64 %
Growth
DHR-PA DHR-PB TMO DHR IDXX A
Asset Growth -8.22 % -8.22 %
Gross Profit Growth 1.23 % 1.23 %
Revenue Growth -0.06 % -0.06 %
Revenue 3 Year -20.76 % -20.76 %
Revenue 5 Year 30.38 % 30.38 %
Revenue 10 Year 15.17 % 15.17 %
EBIT Growth -7.67 % -7.67 %
Net Income Growth -18.16 % -18.16 %
Net Income 3 Yeari Growth Per Share -40.75 % -40.75 %
Net Income 5 Yeari Growth Per Share 49.13 % 49.13 %
Net Income 10 Yeari Growth Per Share 44.14 % 44.14 %
Operating Income Growth -1.8 % -1.8 %
Operating Cash Flow Growth (CFG) -6.64 % -6.64 %
Operating 3 Year CFG -21.78 % -21.78 %
Operating 5 Year CFG 65.54 % 65.54 %
Operating 10 Year CFG 70.94 % 70.94 %
EPS Growth -17.24 % -17.24 %
EPS Diluted Growth -17.08 % -17.08 %
Book Value Per Share -6.67 % -6.67 %
Share Holder 3 Year Equity Growth Per Share 7.23 % 7.23 %
Share Holder 5 Year Equity Growth Per Share 60.08 % 60.08 %
Share Holder 10 Year Equity Growth Per Share 103.57 % 103.57 %
Dividend Per Share Growth -5.75 % -5.75 %
Dividend 3 Year Growth Per Share 1.18 % 1.18 %
Dividend 5 Year Growth Per Share 42.62 % 42.62 %
Dividend 10 Year Growth Per Share 224 % 224 %
Debt Growth -12.23 % -12.23 %
Free Cash Flow Growth -8.39 % -8.39 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
DHR-PA DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 61.37 % 61.37 % 39.81 % 61.37 % 61.72 % 52.43 %
Return on Assets TTM 4.38 % 4.38 % 6.38 % 4.38 % 30.34 % 10.24 %
Return on Equity TTM 6.88 % 6.88 % 13.11 % 6.88 % 67.78 % 20.62 %
Return on Capital Employed TTM 7.31 % 7.31 % 9.04 % 7.31 % 61.18 % 14.25 %
Net Income Per EBT TTM 83.9 % 83.9 % 92.29 % 83.9 % 80.67 % 90.8 %
EBT Per Ebit TTM 77.59 % 77.59 % 89.34 % 77.59 % 97.51 % 97.03 %
EBIT Per Revenue TTM 22.17 % 22.17 % 18.22 % 22.17 % 31.34 % 21.29 %
Cash Flow To Debt Ratio TTM 37.48 % 37.48 % 21.44 % 37.48 % 97.76 % 46.48 %
Receivables Turnover TTM 6.46 6.46 4.91 6.46 5.83 4.67
Payables Turnover TTM 5.52 5.52 8.83 5.52 13.05 5.8
Inventory Turnover TTM 3.51 3.51 4.58 3.51 4.07 3.22
Fixed Asset Turnover TTM 451.41 % 451.41 % 429.75 % 451.41 % 480.31 % 343.45 %
Asset Turnover TTM 30.37 % 30.37 % 42.45 % 30.37 % 123.05 % 54.59 %
Operating Cash Flow Per Share TTM 8.89 8.89 20.24 8.89 13.58 5.51
Free Cash Flow Per Share TTM 7.06 7.06 16.17 7.06 11.91 4.07
Cash Per Share TTM 215 % 215 % 938.1 % 215 % 259.9 % 632.16 %
Operating Cash Flow Sales Ratio TTM 26.03 % 26.03 % 17.49 % 26.03 % 26.11 % 22.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 79.41 % 79.41 % 79.87 % 79.41 % 87.64 % 73.89 %
Cash Flow Coverage Ratios TTM 37.48 % 37.48 % 21.44 % 37.48 % 97.76 % 46.48 %
Price To Free Cash Flows Ratio TTM 33.61 32.91 35.94 32.91 56.1 33.95
Price To Operating Cash Flows Ratio TTM 26.48 25.92 28.63 25.92 49.32 25.04
Price Cash Flow Ratio TTM 26.48 25.92 28.63 25.92 49.32 25.04
Income Statement (TTM)
DHR-PA DHR-PB TMO DHR IDXX A
Revenue $23.88B $23.88B $42.88B $23.88B $3.9B $6.95B
Gross Profit $14.21B $14.21B $17.73B $14.21B $2.38B $3.64B
Gross Profit Ratio 59.5% 59.5% 41.34% 59.5% 61.04% 52.43%
EBITDA $7.28B $7.28B $11.8B $7.28B $1.28B $1.84B
Net Income $3.9B $3.9B $6.34B $3.9B $0.89B $1.3B
EPS Diluted 5.29 5.29 16.53 5.29 10.67 4.57
Balance Sheet (MRQ)
DHR-PA DHR-PB TMO DHR IDXX A
Long Term Debt $16.47B $16.47B $30.3B $16.47B $0.55B $3.05B
Total Liabilities $27.99B $27.99B $47.65B $27.99B $1.7B $5.99B
Total Equity $49.55B $49.55B $49.67B $49.55B $1.6B $6.74B
Total Investments $1.82B $1.82B $2.12B $1.82B $0.06B $0.13B
Total Debt $17.15B $17.15B $32.78B $17.15B $0.99B $3.35B
Total Assets $77.54B $77.54B $97.32B $77.54B $3.29B $12.73B
Cash Flow Statement (TTM)
DHR-PA DHR-PB TMO DHR IDXX A
Net Income $3.9B $3.9B $6.34B $3.9B $0.89B $0.43B
Inventory $0.15B $0.15B $-0.03B $0.15B $-0.03B $0.05B
Dividends Paid $-0.77B $-0.77B $-0.58B $-0.77B $0B $-0.28B
Operating Cash Flow $6.69B $6.69B $8.67B $6.69B $0.93B $1.56B
Capital Expenditure $-1.39B $-1.39B $-1.4B $-1.39B $-0.13B $-0.41B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 147.6
ACRS Aclaris Therapeutics, Inc. 2.645
ADVB Advanced Biomed Inc. Common Stock 0.3442
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 6.03
BIAF bioAffinity Technologies, Inc. 1.305
BIAFW bioAffinity Technologies, Inc. 0.33
BIOC Biocept, Inc. 0.4349
BLLN BillionToOne, Inc. 94.93
BNGO Bionano Genomics, Inc. 1.62
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 19.1
CDNA CareDx, Inc 18.82
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.61
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 216.275
Unlock